prompting maternal admission on [**2178-7-8**] and maternal treatment with betamethasone.
She was maintained on bed rest and monitored, and on [**7-11**], fetal decelerations were noted prompting c-section delivery.
Infant was born by cesarean section under spinal anesthesia.
Apgars were 8 at 1 minute, and 8 at 5 minutes, and the infant was admitted to the neonatal intensive care unit for treatment of prematurity.
SUMMARY OF HOSPITAL COURSE BY SYSTEMS:  RESPIRATORY: [**Known lastname **] was started on nasal cannula oxygen.
His respiratory distress escalated and he was placed on continued positive airway pressure, but was found to have an increasing FIO2 requirement.
He was therefore intubated, given surfactant, and begun on mechanical ventilation.
Maximal ventilatory settings included PIP 24, PEEP 6, and rate of 25.
He was extubated to CPAP on day of life 4, and transitioned to nasal cannula oxygen on day of life.
FLUIDS, ELECTROLYTES AND NUTRITION: [**Known lastname **] was initially NPO and treated with intravenous fluids.
Enteral feeds were started on day of life 4 and gradually advanced to full volume.
At the time of discharge he is breastfeeding or taking breast milk fortified to 24 calories per ounce with Enfamil powder adequately on a PO ad lib basis.
Blood culture was obtained prior to starting intravenous ampicillin and gentamycin.
Blood culture showed no growth at 48 hours and the antibiotics were discontinued.
Initial hematocrit was 59, and he was begun on supplemental iron.
GASTROINTESTINAL:  [**Known lastname **] required treatment for unconjugated hyperbilirubinemia with phototherapy.
He received phototherapy for approximately 72 hours.
Medications - ferrous sulfate 0.2 ml PO once daily, 25 mg    per ml solution.
Vi-Daylin 1 ml PO once daily.
Immunizations received - hepatitis B vaccine was    administered on [**2178-7-21**].
IMMUNIZATIONS RECOMMENDED: 1.
Synagis RSV prophylaxis should be considered from [**Month (only) **]    through [**Month (only) 958**] for infants who meet any of the following    three criteria.
Influenza immunization is recommended annually in the Fall    for all infants once they reach 6 months of age.
